Katherine L Werbaneth, M.D.
Investigator
Katherine Werbaneth, MD is a neurologist with specialized training in epilepsy and electroencephalography (EEG). Her clinical and research efforts focus on seizure disorders, status epilepticus, and the application of advanced EEG technologies to improve diagnostic accuracy and treatment outcomes in critically ill patients. Dr. Werbaneth has authored and co‑authored multiple peer‑reviewed publications examining seizure clusters, rapid and high‑density EEG utilization, non‑convulsive status epilepticus, and new‑onset refractory status epilepticus (NORSE). Her work has been published in journals including Epilepsy & Behavior, Epileptic Disorders, Seizure, and Clinical Neurology and Neurosurgery. Through multidisciplinary collaboration, her research emphasizes the translation of innovative neurodiagnostic tools into clinical practice to support timely, evidence‑based decision‑making and improved neurologic outcomes.
Clinical trials
A Phase 2b, Multi-center, Randomized, Double-blind, Placebo-controlled Study of IMVT-1402 Treatment in Adult Participants With Chronic Inflammatory Demyelinating Polyneuropathy (CIDP)
Status: Open to Enrollment




